List of Tables
Table 1. Common Drugs Use in Ophthalmology Market Trends
Table 2. Common Drugs Use in Ophthalmology Market Drivers & Opportunity
Table 3. Common Drugs Use in Ophthalmology Market Challenges
Table 4. Common Drugs Use in Ophthalmology Market Restraints
Table 5. Global Common Drugs Use in Ophthalmology Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Common Drugs Use in Ophthalmology Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Common Drugs Use in Ophthalmology Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Common Drugs Use in Ophthalmology Product Type
Table 9. Key Companies Time to Begin Mass Production of Common Drugs Use in Ophthalmology
Table 10. Global Common Drugs Use in Ophthalmology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Common Drugs Use in Ophthalmology as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Common Drugs Use in Ophthalmology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Common Drugs Use in Ophthalmology Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Common Drugs Use in Ophthalmology Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Common Drugs Use in Ophthalmology Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Common Drugs Use in Ophthalmology Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Common Drugs Use in Ophthalmology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Common Drugs Use in Ophthalmology Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Common Drugs Use in Ophthalmology Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Common Drugs Use in Ophthalmology Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Common Drugs Use in Ophthalmology Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Common Drugs Use in Ophthalmology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Common Drugs Use in Ophthalmology Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Common Drugs Use in Ophthalmology Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Common Drugs Use in Ophthalmology Sales Value by Region (2019-2024) & (%)
Table 27. Global Common Drugs Use in Ophthalmology Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Common Drugs Use in Ophthalmology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Common Drugs Use in Ophthalmology Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Common Drugs Use in Ophthalmology Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 34. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Novartis Basic Information List
Table 37. Novartis Description and Business Overview
Table 38. Novartis Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 39. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Novartis (2019-2024)
Table 40. Novartis Recent Developments
Table 41. Bausch Health Basic Information List
Table 42. Bausch Health Description and Business Overview
Table 43. Bausch Health Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 44. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Bausch Health (2019-2024)
Table 45. Bausch Health Recent Developments
Table 46. Fresenius Basic Information List
Table 47. Fresenius Description and Business Overview
Table 48. Fresenius Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 49. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Fresenius (2019-2024)
Table 50. Fresenius Recent Developments
Table 51. Teva Pharmaceutical Basic Information List
Table 52. Teva Pharmaceutical Description and Business Overview
Table 53. Teva Pharmaceutical Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 54. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Teva Pharmaceutical (2019-2024)
Table 55. Teva Pharmaceutical Recent Developments
Table 56. Allergan Basic Information List
Table 57. Allergan Description and Business Overview
Table 58. Allergan Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 59. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Allergan (2019-2024)
Table 60. Allergan Recent Developments
Table 61. Mylan Basic Information List
Table 62. Mylan Description and Business Overview
Table 63. Mylan Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 64. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Mylan (2019-2024)
Table 65. Mylan Recent Developments
Table 66. Santen Pharmaceutical Basic Information List
Table 67. Santen Pharmaceutical Description and Business Overview
Table 68. Santen Pharmaceutical Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 69. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Santen Pharmaceutical (2019-2024)
Table 70. Santen Pharmaceutical Recent Developments
Table 71. Takeda Basic Information List
Table 72. Takeda Description and Business Overview
Table 73. Takeda Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 74. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Takeda (2019-2024)
Table 75. Takeda Recent Developments
Table 76. Johnson & Johnson Basic Information List
Table 77. Johnson & Johnson Description and Business Overview
Table 78. Johnson & Johnson Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 79. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Johnson & Johnson (2019-2024)
Table 80. Johnson & Johnson Recent Developments
Table 81. APOTEX Basic Information List
Table 82. APOTEX Description and Business Overview
Table 83. APOTEX Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 84. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of APOTEX (2019-2024)
Table 85. APOTEX Recent Developments
Table 86. GE Medical Basic Information List
Table 87. GE Medical Description and Business Overview
Table 88. GE Medical Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 89. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of GE Medical (2019-2024)
Table 90. GE Medical Recent Developments
Table 91. Jamp Pharma Basic Information List
Table 92. Jamp Pharma Description and Business Overview
Table 93. Jamp Pharma Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 94. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Jamp Pharma (2019-2024)
Table 95. Jamp Pharma Recent Developments
Table 96. Senju Pharmaceutical Basic Information List
Table 97. Senju Pharmaceutical Description and Business Overview
Table 98. Senju Pharmaceutical Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 99. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Senju Pharmaceutical (2019-2024)
Table 100. Senju Pharmaceutical Recent Developments
Table 101. Chongqing Chemical & Pharmaceutical Holding (Group) Company Basic Information List
Table 102. Chongqing Chemical & Pharmaceutical Holding (Group) Company Description and Business Overview
Table 103. Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 104. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Chongqing Chemical & Pharmaceutical Holding (Group) Company (2019-2024)
Table 105. Chongqing Chemical & Pharmaceutical Holding (Group) Company Recent Developments
Table 106. Sun Pharmaceutical Basic Information List
Table 107. Sun Pharmaceutical Description and Business Overview
Table 108. Sun Pharmaceutical Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 109. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Sun Pharmaceutical (2019-2024)
Table 110. Sun Pharmaceutical Recent Developments
Table 111. Taj Pharmaceuticals Basic Information List
Table 112. Taj Pharmaceuticals Description and Business Overview
Table 113. Taj Pharmaceuticals Common Drugs Use in Ophthalmology Products, Services and Solutions
Table 114. Revenue (US$ Million) in Common Drugs Use in Ophthalmology Business of Taj Pharmaceuticals (2019-2024)
Table 115. Taj Pharmaceuticals Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Common Drugs Use in Ophthalmology Downstream Customers
Table 119. Common Drugs Use in Ophthalmology Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Common Drugs Use in Ophthalmology Product Picture
Figure 2. Global Common Drugs Use in Ophthalmology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Common Drugs Use in Ophthalmology Sales Value (2019-2030) & (US$ Million)
Figure 4. Common Drugs Use in Ophthalmology Report Years Considered
Figure 5. Global Common Drugs Use in Ophthalmology Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Common Drugs Use in Ophthalmology Revenue in 2023
Figure 7. Common Drugs Use in Ophthalmology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Anti-inflammatory Drugs Picture
Figure 9. Anti-infective Drugs Picture
Figure 10. Anti-glaucoma Drugs Picture
Figure 11. Anti-allergy Drugs Picture
Figure 12. Anti-VEGF Agents Picture
Figure 13. Others Picture
Figure 14. Global Common Drugs Use in Ophthalmology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Common Drugs Use in Ophthalmology Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Dry Eye
Figure 17. Product Picture of Glaucoma
Figure 18. Product Picture of Infection/Inflammation
Figure 19. Product Picture of Retinal Disorders
Figure 20. Product Picture of Others
Figure 21. Global Common Drugs Use in Ophthalmology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Common Drugs Use in Ophthalmology Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Common Drugs Use in Ophthalmology Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Common Drugs Use in Ophthalmology Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Common Drugs Use in Ophthalmology Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Common Drugs Use in Ophthalmology Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Common Drugs Use in Ophthalmology Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Common Drugs Use in Ophthalmology Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Common Drugs Use in Ophthalmology Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Common Drugs Use in Ophthalmology Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Common Drugs Use in Ophthalmology Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Common Drugs Use in Ophthalmology Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Common Drugs Use in Ophthalmology Sales Value (%), (2019-2030)
Figure 34. United States Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 40. China Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 42. China Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 52. India Common Drugs Use in Ophthalmology Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Common Drugs Use in Ophthalmology Sales Value by Type (%), 2023 VS 2030
Figure 54. India Common Drugs Use in Ophthalmology Sales Value by Application (%), 2023 VS 2030
Figure 55. Common Drugs Use in Ophthalmology Industrial Chain
Figure 56. Common Drugs Use in Ophthalmology Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
